PL2480075T3 - Kompozycje i sposoby indukowania lub wzmagania naprawy tkanki łącznej - Google Patents

Kompozycje i sposoby indukowania lub wzmagania naprawy tkanki łącznej

Info

Publication number: PL2480075T3
Authority: PL; Poland
Prior art keywords: inducing; compositions; methods; connective tissue; tissue repair
Prior art date: 2009-09-23

Application number

PL10819325T

Other languages

English (en)

Inventor

Peter Byron Buckley

Konrad Messmer

Mark William Phillips

Original Assignee

Glenpharma Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-09-23

Filing date

2010-09-21

Publication date

2021-01-11

2010-09-21 Application filed by Glenpharma Ab filed Critical Glenpharma Ab

2021-01-11 Publication of PL2480075T3 publication Critical patent/PL2480075T3/pl

Links

210000002808 connective tissue Anatomy 0.000 title 1
230000002708 enhancing effect Effects 0.000 title 1
230000001939 inductive effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
230000017423 tissue regeneration Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL10819325T 2009-09-23 2010-09-21 Kompozycje i sposoby indukowania lub wzmagania naprawy tkanki łącznej PL2480075T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27242709P	2009-09-23	2009-09-23
EP10819325.1A EP2480075B1 (en)	2009-09-23	2010-09-21	Compositions and methods for inducing or enhancing connective tissue repair
PCT/US2010/049640 WO2011037912A1 (en)	2009-09-23	2010-09-21	Compositions and methods for inducing or enhancing connective tissue repair

Publications (1)

Publication Number	Publication Date
PL2480075T3 true PL2480075T3 (pl)	2021-01-11

Family

ID=43796166

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10819325T PL2480075T3 (pl)	2009-09-23	2010-09-21	Kompozycje i sposoby indukowania lub wzmagania naprawy tkanki łącznej

Country Status (11)

Country	Link
US (2)	US9180089B2 (pl)
EP (1)	EP2480075B1 (pl)
CN (1)	CN102665412B (pl)
AU (1)	AU2010298484B2 (pl)
CA (1)	CA2773776C (pl)
DK (1)	DK2480075T3 (pl)
ES (1)	ES2819222T3 (pl)
HU (1)	HUE050574T2 (pl)
PL (1)	PL2480075T3 (pl)
SI (1)	SI2480075T1 (pl)
WO (1)	WO2011037912A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2686114T3 (es)	2011-12-20	2018-10-16	Angioclinic Ag	El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas
CN102836424B (zh) *	2012-09-25	2014-03-19	中国人民解放军第四军医大学	一种预防及治疗瘢痕的疫苗及制备方法
AU2017257956B2 (en) *	2016-04-27	2019-11-07	Anika Therapeutics, Inc.	Compositions for use in treating tendon degeneration
US9861410B2 (en)	2016-05-06	2018-01-09	Medos International Sarl	Methods, devices, and systems for blood flow
CN106943619A (zh) *	2017-03-17	2017-07-14	清华大学	一种液体伤口敷料及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5872598A (ja) *	1981-10-26	1983-04-30	Hayashibara Biochem Lab Inc	高純度イソマルト−スの製造方法
SE442820B (sv) *	1984-06-08	1986-02-03	Pharmacia Ab	Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
SE8900586L (sv) *	1989-02-21	1990-08-22	Pharmacia Ab	Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US6255295B1 (en) *	1996-12-23	2001-07-03	Nutramax Laboratories, Inc.	Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6303585B1 (en) *	1997-07-03	2001-10-16	Orquest, Inc.	Cross-linked polysaccharide drug carrier
US5902800A (en) *	1998-03-27	1999-05-11	Glenpharma	Dextran formulations and method for treatment of inflammatory joint disorders
US20030130205A1 (en) *	2000-04-12	2003-07-10	Christian Samuel T.	Novel pharmaceutical anti-infective agents containing carbohydrate moieties and methods of their preparation and use
WO2005000402A2 (en)	2003-05-15	2005-01-06	University Of Utah Research Foundation	Anti-adhesion composites and methods os use thereof
NZ547140A (en) *	2003-10-22	2009-09-25	Encelle Inc	Bioactive hydrogel compositions in dehydrated form for regenerating connective tissue
AU2004297231B2 (en)	2003-12-04	2012-02-02	University Of Utah Research Foundation	Modified macromolecules and associated methods of synthesis and use
US8288362B2 (en) *	2004-05-07	2012-10-16	S.K. Pharmaceuticals, Inc.	Stabilized glycosaminoglycan preparations and related methods
DE602004027120D1 (de) *	2004-05-25	2010-06-24	Cognis Ip Man Gmbh	Orale und/oder topische Zubereitungen
US7348062B2 (en) *	2006-06-10	2008-03-25	Solutia Incorporated	Interlayers comprising modified fumed silica
WO2008156354A1 (en) *	2007-06-21	2008-12-24	N.V. Nutricia	Modulation of intestinal flora of hiv patients

2010
- 2010-09-21 ES ES10819325T patent/ES2819222T3/es active Active
- 2010-09-21 DK DK10819325.1T patent/DK2480075T3/da active
- 2010-09-21 PL PL10819325T patent/PL2480075T3/pl unknown
- 2010-09-21 EP EP10819325.1A patent/EP2480075B1/en active Active
- 2010-09-21 CA CA2773776A patent/CA2773776C/en active Active
- 2010-09-21 SI SI201032032T patent/SI2480075T1/sl unknown
- 2010-09-21 AU AU2010298484A patent/AU2010298484B2/en active Active
- 2010-09-21 US US13/496,933 patent/US9180089B2/en not_active Expired - Fee Related
- 2010-09-21 WO PCT/US2010/049640 patent/WO2011037912A1/en not_active Ceased
- 2010-09-21 HU HUE10819325A patent/HUE050574T2/hu unknown
- 2010-09-21 CN CN201080051615.7A patent/CN102665412B/zh active Active
2015
- 2015-10-28 US US14/925,367 patent/US9795630B2/en active Active

Also Published As

Publication number	Publication date
CN102665412B (zh)	2015-03-04
US9180089B2 (en)	2015-11-10
EP2480075B1 (en)	2020-07-01
SI2480075T1 (sl)	2020-11-30
DK2480075T3 (da)	2020-09-28
WO2011037912A1 (en)	2011-03-31
ES2819222T3 (es)	2021-04-15
EP2480075A4 (en)	2015-03-11
EP2480075A1 (en)	2012-08-01
CN102665412A (zh)	2012-09-12
US20120177600A1 (en)	2012-07-12
AU2010298484B2 (en)	2014-09-25
CA2773776C (en)	2018-09-25
AU2010298484A1 (en)	2012-04-05
US20160045534A1 (en)	2016-02-18
HUE050574T2 (hu)	2020-12-28
CA2773776A1 (en)	2011-03-31
US9795630B2 (en)	2017-10-24

Publication	Publication Date	Title
PL2211741T3 (pl)	2013-10-31	Naprawa złamania okołoprotezowego
IL206972A0 (en)	2010-12-30	Apparatus and methods for fracture repair
PL2442750T3 (pl)	2019-10-31	Postacie stałe do naprawy tkanek
IL219891A0 (en)	2012-07-31	Lipopeptide compositions and related methods
PT2482841T (pt)	2019-03-01	A presente invenção refere-se à utilização de lactonas macrocíclicas para o tratamento da demodicose, em particular em cães.
PT2367556T (pt)	2019-03-25	Formas sólidas para reparação de tecido
EP2429584A4 (en)	2013-02-20	TREATMENT PROCEDURE AND COMPOSITIONS
IL210097B (en)	2018-08-30	Compounds and methods for the treatment of influenza
PT2442729T (pt)	2018-11-20	Método e kit de reparação de tecidos
ZA201007830B (en)	2011-07-27	Compositions and methods for immunity
EP2512483A4 (en)	2013-06-05	BALAGLITAZON COMPOSITIONS AND METHOD THEREFOR
SI2480075T1 (sl)	2020-11-30	Sestavki in postopki za induciranje ali povečanje reparacije vezivnega tkiva
GB0901494D0 (en)	2009-03-11	Compositions and Methods
HK1172502A (en)	2013-04-26	Compositions and methods for inducing or enhancing connective tissue repair
HK1172502B (en)	2021-04-16	Compositions and methods for inducing or enhancing connective tissue repair
GB0813621D0 (en)	2008-09-03	Enhancement of fracture repair
AU2009906034A0 (en)	2009-12-24	Methods and compositions for bone and cartilage repair
GB0714753D0 (en)	2007-09-12	Enhancement of fracture repair
GB0702401D0 (en)	2007-03-21	Connective tissue repair
GB0903913D0 (en)	2009-04-22	Compositions and methods
GB0908498D0 (en)	2009-06-24	Compositions and methods
GB0907616D0 (en)	2009-06-10	Methods and compositions
GB0909720D0 (en)	2009-07-22	Compositions and methods
GB0907093D0 (en)	2009-06-03	Tissue softening methods and compositions
IL216962A0 (en)	2012-02-29	Solid forms for tissue repair